U.S. Markets close in 4 hrs 38 mins

Peregrine Pharmaceuticals, Inc. (PPHM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.150+0.030 (+0.962%)
As of 11:18AM EDT. Market open.
People also watch
GALECTICTHLDXOMACYTR
  • J
    Joey
    Joey
    The 2016 meeting was on Oct 16th. I guess PP can wait until Nov 15th for the next one. Or, beyond.

    "However, if 13 months elapse from the date of the previous shareholder meeting, the Delaware Court of Chancery, which regulates business in the state, can order the annual meeting to be held at the request of a single shareholder or board director. The court also can issue orders specifying the time and place for the meeting, as well as the type of notice that shareholders are to receive."
  • a
    art
    art
    I believe Dr Elias does NOT qualify as the new Fifth INDEPENDENT Board Member!--- The non-employee directors agreed to pay or cause to be paid $1,500,000 to us, which amount is included in trade and other receivables at July 31, 2017 and as a reduction to selling, general and administrative expense in the accompanying unaudited condensed consolidated financial statements for the three months ended July 31, 2017 (payment was received by the Company in full in August 2017).
    · Our Board of Directors agreed to reprice all of the stock options granted to the non-employee directors and executive officers (other than one executive officer whose employment terminated in 2013) on December 27, 2012, from $8.26 per share to $17.01, representing the closing price of our common stock on January 7, 2013 (as adjusted for the one-for-seven reverse stock split effected on July 7, 2017).

    · The non-employee directors agreed to an annual compensation cap (cash and stock compensation) for a two-year period equal to the greater of: (i) $400,000 (comprised of compensation both for service as a director of Peregrine Pharmaceuticals, Inc. and for services as a director of Avid Bioservices, Inc.); or (ii) the 75th percentile of compensation paid by our peer group to their non-employee directors, as determined by an independent compensation consultant.
    · The Board of Directors agreed, contingent upon, and within three (3) months following, the FDA’s approval of bavituximab for marketing in the United States, to increase the authorized number of directors from four to five, and appoint an appropriate and suitable INDEPENDENT candidate to serve as the fifth member.
  • F
    FiduciaryDoozy
    FiduciaryDoozy
    Dear Ronin&Co.,

    Please get the bottom of the Pll trial debacle that saw "Intent" without intending to follow up, the VP of Quality exit, a pricey consultant working on "bigger fish", an overseer contractor that appeared immune to testimony and the suit, a share price that hit margin-able just prior to the early Monday morning timing, a leadership team who never kept shareholders in the loop, a score of ex employees and their CWT. And so on and so forth...

    Thank you.
    Robbed Common Shareholder
  • F
    FiduciaryDoozy
    FiduciaryDoozy
    How many former employees were actively getting paid before Ronin started snooping?
  • F
    FiduciaryDoozy
    FiduciaryDoozy
    Truly amazing how the conversation goes over there on the Hub. Ronin very clearly spelled out the BOD game but Hubbers looking for "3rd option" or hoping to simply kick out the three amigos. Concentration issues over there.

    You just can't make this stuff up.
  • F
    FiduciaryDoozy
    FiduciaryDoozy
    "I can't understand why anyone invested in this company wouldn't hate this BOD..." - Hubber

    Really, you can't? lol.
  • S
    SJ
    SJ
    The haughty self-proclaimed genius with this nauseating post over on the Hump:
    "Business Development for Avid---is Gingrich still around?, lost track of him since I last talked with him in D.C. "
    Really, is ANYONE this much of a doooshbag in real life? He must have bodyguards that keep hordes of people from just sucker punching him on the streets.
    His act is exposing itself for what it is, though. It's possible he's just the deviant CP under another handle.
    EXPOSE IT ALL, RONIN !!!!!!!!!!
  • F
    FiduciaryDoozy
    FiduciaryDoozy
    Peregrind...Patron Saint of those who die waiting.
  • J
    Joey
    Joey
    So far today IHump'ers doing a good job not feeding Bioharm and BODProtector trolls.
  • F
    FiduciaryDoozy
    FiduciaryDoozy
    We'd like to thank all those who "hit the ground running" on what appears to be valueless IP and a disappearing manufacturing business racing to the bottom. The entire team ran up combined salaries and bonuses of hundred of millions of ATM dollars.

    Shockingly well done.
  • F
    FiduciaryDoozy
    FiduciaryDoozy
    Robert L. Garnick
    FORMER Head of Regulatory Affairs at Peregrine Pharmaceuticals, Inc.
  • S
    SJ
    SJ
    self-proclaimed genius north40000 (40000 is his IQ you know, just ask him if he doesn't bring it up himself first) is exposing himself not only as a dislikeable doooshbag - but as a full-blown shill of the company management cabal. . Not-My-Spouse wants him in a cage match to the finish for no pay - Just for the enjoyment of whupping up on an adz hole.
    I told her she's gotta stand in line.
  • F
    FiduciaryDoozy
    FiduciaryDoozy
    Shelley P. M. Fussey
    FORMER Vice President, Intellectual Property at Peregrine Pharmaceuticals, Inc.

    Surely Ms Fussey must know the value of all that IP.
  • F
    FiduciaryDoozy
    FiduciaryDoozy
    Mary Boyd
    Way FORMER hit the ground running.
  • F
    FiduciaryDoozy
    FiduciaryDoozy
    Looks like another consultant/employee gets to hit the ground running with $600k ATM winnings. Congrats! Lol.
  • F
    FiduciaryDoozy
    FiduciaryDoozy
    Little Kennedy Capital trying to outvote Ronin? 21.65%.

    Kennedy Capital Management Inc. increased its holdings in shares of Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) by 11.8% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,758,459 shares of the biopharmaceutical company’s stock after purchasing an additional 1,028,067 shares during the quarter. Kennedy Capital Management Inc. owned 21.65% of Peregrine Pharmaceuticals worth $5,933,000 at the end of the most recent reporting period.
  • S
    SJ
    SJ
    over on the Hump, poster 'bigbro' admitting to being sorry for getting tied up and buying into this POS criminal company without first checking into its governance or reading 'con' opinions made on social media sites.
    That's why the "bashers" have been posting. . To try to save others from the same ruinous fate. . With years and years and literally tens of thousands of fraudulent pumping posts from the "respected" community over there - coupled with so little real information being shared by PP'er mngmnt - it would be very hard for one to see thru the scam early on.

    Sorry you missed my posts back then, bigbro. . And sorry for your predicament. . Funny I am the one that I-Hump banned while the paid pumper/shorters carry on with huzzahs from the paid accomplices and/or wanna-be-loved lemmings all around.
  • F
    FiduciaryDoozy
    FiduciaryDoozy
    "Pass-trough charges" way up! Need to get to the bottom of it.
  • J
    Joey
    Joey
    Gaddy lied. Cruel.

    As of September 11, 2017, $67,674,000 remained available to us under our effective shelf registration statement (which shelf expires in January 2018), which allows us from time to time to offer and sell shares of our common stock, in one or more offerings, either individually or in combination.
  • R
    Robbed
    Robbed
    All objectors to current BOD. Any time for ASM and proxy? What effect has Kennedy to BOD vote? What chances of takeover?
    Thanks team.